In recent years, the rise of technology as a transformative force in society has become undeniable, especially within the context of China's booming economyThe emergence of the Sci-Tech Innovation Board has provided a robust platform for companies focusing on the high-tech sector, enabling them to thrive amidst a backdrop of governmental support and evolving market dynamicsOne of the most notable indices within this new framework is the Sci-Tech 100, which represents a diverse array of companies positioned between ranks 51 to 150, immediately following the distinguished Sci-Tech 50. As the technology landscape evolves, driven by advancements in various fields—including renewable energy, semiconductors, and artificial intelligence—the investment opportunities that emerge are reminiscent of a myriad of shining stars adorning the night sky.

The measure of success for a sector is often indicated through its prevailing market sentiment

Advertisements

According to several reports, the ongoing expansion of the Sci-Tech 100 reflects a vibrant and promising outlook for investorsSince March 2023, the growth rate of expected profits has surged, reflecting an impressive 58% as compared to other major indices like the CSI 300 and CSI 800. Companies listed on this index exude a strong fundamental base that lends credibility to their growth narratives.

Even as skepticism toward fundamental analysis has been prevalent in recent years, particularly among retail investors, it is essential that decision-making processes do not completely disregard fundamental assessmentsCompanies that showcase solid profitability and robust fundamental characteristics remain coveted assets within the marketThis principle holds more weight than ever when examining the Sci-Tech 100 index closelyThe constituents of this index predominantly come from high-tech sectors such as pharmaceuticals, electronics, electrical equipment, machinery, and computing, with a collective weight exceeding 90%. Crucially, this index includes numerous rare and leading players in niche markets, notably in the fields of orthopedics and cardiac valves, where domestic brands such as Weigao Orthopedic and Bairen Medical stand out

Advertisements

Such firms excel in their respective domains, indicated by their leadership in technological innovation.

Moreover, development and research investment is a key indicator of a company’s potential for growth and innovationDespite facing slow overall economic growth in recent years, companies under the Sci-Tech 100 index remarkably maintained a high level of research intensity, signaling commitment to innovationAs evidenced by statistics from the Shanghai Stock Exchange, these companies allocated a staggering 28.9 billion yuan to research and development in the year 2022, accounting for an average of 19% of their total sales revenueNotably, in the past three years, their compound annual revenue growth rate has reached an impressive 38.9%, underscoring their dominant position relative to the broader market metrics.

As we delve into the financial market further, we begin to discern the implications of pricing on investment decisions

Advertisements

The principle of selecting high-quality indices sets the stage for understanding price dynamicsSince the peak observed in 2020, the Sci-Tech 100 index has experienced a significant decline, suggesting that it has possibly reached attractive valuations that provide promising return prospectsBroad-based indices are structurally resilient, and when subjected to meaningful corrections, they often present immense rebound potentialThe optimistic growth prospects coupled with favorable fundamentals for the Sci-Tech Board indicate that an upswing is likely imminent.

The characteristics of the Sci-Tech 100 index featured include a majority of small to medium-sized companies, with median market capitalizations of around 12 billion yuanThis growth-oriented composition is heavily tilted toward emerging industries, meaning that constituent companies are often leaders within their specialized sectors

• Promoting Safe and Orderly Development of Nuclear Energy
• Nvidia Loses $240B in Market Value Overnight
• U.S. JOLTS Job Openings Exceed Expectations
• Elevating the Full Chain of China's Automotive Industry
• Anthropic Seeks $2B at $60B Valuation

Despite the higher risks associated with smaller capitalization stocks—such as potential turmoil or volatility—the upside potential for growth in future endeavors also remains significantFrom its zenith in July 2020, the index witnessed a staggering drop of approximately 54%. Such considerable declines typically lead to increased chances of recovery in the market environment.

Historically, during extensive market rebounds, the Sci-Tech 100 index consistently outperformed its larger counterpart, the Sci-Tech 50. Consequently, during periods of market uptrend, the cumulative returns of the Sci-Tech 100 index have significantly surpassed those of other broad indices, reinforcing investor confidence in its potential for substantial returns.

INSIGHTS: It's worth noting the increasing interest from institutional players focusing on medium to small-cap stocks, indicative of a broader market trend favoring this segment

A prime example includes the rapid growth of the Sci-Tech 100 Exchange Traded Fund (ETF), denoted by the ticker 588190. Recent observations reveal an impressive increase in both the fund share volumes and trading activityFrom early November to mid-November, the share volume of the Sci-Tech 100 ETF surged from 1.87 billion to 2.69 billion, amounting to a remarkable growth rate of 43.9%. Concurrently, the trading volume expanded from 277 million to 444 million yuan, achieving a remarkable 60% increaseSuch movements validate the rising trend among investors who are strategically allocating through the Sci-Tech 100 ETF, fortifying their positions in the small-cap technology sector.

Furthermore, the Sci-Tech Board has evolved into a significant battlefield for public fund investmentsBy the end of the third quarter, actively managed equity funds have positioned their allocations within the Sci-Tech Board at 9.43%, indicating a continued overweight stance